Bioxytran Using Paradigm Changing Vital Sign that Can Measure Real Time Tissue Oxygen Balance in Emergency Medicine
20 mai 2019 07h05 HE
|
Bioxytran Inc.
Future use of the MDX Viewer likely to start in operating rooms, clinical trials to measure tissue balance in stroke, and to test the viability of an organ before transplantation BOSTON,...
Bioxytran Inc. Announces Appointment of Ex Bristol-Myers Squibb Executive to Scientific Advisory Board
06 mai 2019 07h08 HE
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, May 06, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of anti-necrosis drugs designed to treat...
Bioxytran Licensing FDA Approved Technology from MDX Lifesciences for use in Pipeline Drug Development
04 avr. 2019 07h00 HE
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, April 04, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company with a pipeline of anti-necrosis drugs designed to treat hypoxia by...
Bioxytran, Inc. Engages Resources Unlimited NW, LLC. for Strategic Investor Relations
18 mars 2019 07h00 HE
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, March 18, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company, with a pipeline of anti-necrosis drugs designed to treat hypoxia...
Bioxytran, Inc. Pioneers First Emergency Stroke Treatment
17 déc. 2018 07h00 HE
|
Bioxytran Inc.
Newly Developed Molecule Potentially Allows Oxygen Flow to the Brain BOSTON, MASSACHUSETTS, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Bioxytran Inc. (BIXT). Dr. David Platt, CEO of newly formed...
Bioxytran Inc’s New Compound for Treating Strokes Will be the Company’s New Health Mission Moving Forward
12 nov. 2018 07h00 HE
|
Bioxytran Inc.
Company Formerly Known as U.S. Rare Earth Minerals, Inc. Focusing on First-In-Class Ischemic Stroke Treatment BOSTON, Nov. 12, 2018 (GLOBE NEWSWIRE) -- U.S. Rare Earth Minerals, Inc. today...